These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 8892397)
21. Effect of 6-aminonicotinamide on renin release in isolated rat kidney: possible role for the pentose pathway. Rostand SG; Work J Am J Physiol; 1985 Aug; 249(2 Pt 2):F213-9. PubMed ID: 3161339 [TBL] [Abstract][Full Text] [Related]
22. Plasma uridine changes in cancer patients treated with the combination of dipyridamole and N-phosphonacetyl-L-aspartate. Chan TC; Markman M; Cleary S; Howell SB Cancer Res; 1986 Jun; 46(6):3168-72. PubMed ID: 3698032 [TBL] [Abstract][Full Text] [Related]
23. In vivo and ex vivo study of metabolic and cellular effects of 5-fluorouracil chemotherapy in a mouse mammary carcinoma. Street JC; Alfieri AA; Traganos F; Koutcher JA Magn Reson Imaging; 1997; 15(5):587-96. PubMed ID: 9254003 [TBL] [Abstract][Full Text] [Related]
24. N-(phosphonacetyl)-L-aspartate synergistically enhances the cytotoxicity of 5-fluorouracil/interferon-alpha-2a against human colon cancer cell lines. Wadler S; Mao X; Bajaj R; Hallam S; Schwartz EL Mol Pharmacol; 1993 Nov; 44(5):1070-6. PubMed ID: 8246910 [TBL] [Abstract][Full Text] [Related]
25. A phase I study of continuous infusion 5-fluorouracil plus calcium leucovorin in combination with N-(phosphonacetyl)-L-aspartate in metastatic gastrointestinal adenocarcinoma. Grem JL; McAtee N; Steinberg SM; Hamilton JM; Murphy RF; Drake J; Chisena T; Balis F; Cysyk R; Arbuck SG Cancer Res; 1993 Oct; 53(20):4828-36. PubMed ID: 8402669 [TBL] [Abstract][Full Text] [Related]
26. Metabolism via the pentose phosphate pathway in rat pheochromocytoma PC12 cells: effects of nerve growth factor and 6-aminonicotinamide. Davis LH; Kauffman FC Neurochem Res; 1987 Jun; 12(6):521-7. PubMed ID: 2955240 [TBL] [Abstract][Full Text] [Related]
28. Enhanced antitumor activity of an adriamycin + 5-fluorouracil combination when preceded by biochemical modulation. Stolfi RL; Colofiore JR; Nord LD; Martin DS Anticancer Drugs; 1996 Jan; 7(1):100-4. PubMed ID: 8742105 [TBL] [Abstract][Full Text] [Related]
29. Mechanism of synergy between N-phosphonacetyl-L-aspartate and dipyridamole in a human ovarian carcinoma cell line. Chan TC; Howell SB Cancer Res; 1985 Aug; 45(8):3598-604. PubMed ID: 4016741 [TBL] [Abstract][Full Text] [Related]
30. Mechanism of resistance of variants of the Lewis lung carcinoma to N-(phosphonacetyl)-L-aspartic acid. Kensler TW; Mutter G; Hankerson JG; Reck LJ; Harley C; Han N; Ardalan B; Cysyk RL; Johnson RK; Jayaram HN; Cooney DA Cancer Res; 1981 Mar; 41(3):894-904. PubMed ID: 7459875 [TBL] [Abstract][Full Text] [Related]
31. Antitumor activity of the weekly intravenous push schedule of 5-fluoro-2'-deoxyuridine +/- N-phosphonacetyl-L-aspartate in mice bearing advanced colon carcinoma 26. van Laar JA; Durrani FA; Rustum YM Cancer Res; 1993 Apr; 53(7):1560-4. PubMed ID: 8453623 [TBL] [Abstract][Full Text] [Related]
32. Phase I study of N-(phosphonacetyl)-L-aspartate with fluorouracil and with or without dipyridamole in patients with advanced cancer. Fleming RA; Capizzi RL; Muss HB; Smith S; Fernandes DJ; Homesley H; Loggie BW; Case L; Morris R; Russell GB; Richards F Clin Cancer Res; 1996 Jul; 2(7):1107-14. PubMed ID: 9816275 [TBL] [Abstract][Full Text] [Related]
33. Phase I and clinical pharmacological evaluation of biochemical modulation of 5-fluorouracil with N-(phosphonacetyl)-L-aspartic acid. Casper ES; Vale K; Williams LJ; Martin DS; Young CW Cancer Res; 1983 May; 43(5):2324-9. PubMed ID: 6831457 [TBL] [Abstract][Full Text] [Related]
34. 6-Aminonicotinamide sensitizes human tumor cell lines to cisplatin. Budihardjo II; Walker DL; Svingen PA; Buckwalter CA; Desnoyers S; Eckdahl S; Shah GM; Poirier GG; Reid JM; Ames MM; Kaufmann SH Clin Cancer Res; 1998 Jan; 4(1):117-30. PubMed ID: 9516960 [TBL] [Abstract][Full Text] [Related]
35. Correlations between 31P-NMR spectroscopy and tissue O2 tension measurements in a murine fibrosarcoma. Vaupel P; Okunieff P; Kallinowski F; Neuringer LJ Radiat Res; 1989 Dec; 120(3):477-93. PubMed ID: 2594969 [TBL] [Abstract][Full Text] [Related]
36. Effect of N-(phosphonacetyl)-L-aspartate on 5-azacytidine metabolism in P388 and L1210 cells. Grant S; Rauscher F; Jakubowski A; Cadman E Cancer Res; 1981 Feb; 41(2):410-8. PubMed ID: 6160908 [TBL] [Abstract][Full Text] [Related]
37. Dietary fat modulation of murine mammary tumor metabolism studied by in vivo 31P-nuclear magnetic resonance spectroscopy. Buckman DK; Erickson KL; Ross BD Cancer Res; 1987 Nov; 47(21):5631-6. PubMed ID: 3664470 [TBL] [Abstract][Full Text] [Related]
38. The effect of gossypol and 6-aminonicotinamide on tumor cell metabolism: a 31P-magnetic resonance spectroscopic study. Keniry MA; Hollander C; Benz CC Biochem Biophys Res Commun; 1989 Oct; 164(2):947-53. PubMed ID: 2530981 [TBL] [Abstract][Full Text] [Related]
39. In vivo 31P-NMR spectroscopy of murine tumours before and after localized hyperthermia. Vaupel P; Okunieff P; Neuringer LJ Int J Hyperthermia; 1990; 6(1):15-31. PubMed ID: 2299228 [TBL] [Abstract][Full Text] [Related]
40. 6-Aminonicotinamide inhibition of the pentose phosphate pathway in rat neocortex. Tyson RL; Perron J; Sutherland GR Neuroreport; 2000 Jun; 11(9):1845-8. PubMed ID: 10884030 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]